Sign inOpen the app
Artwork for BioBoss
Science

BioBoss

John Simboli

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
SubscribeListen in podnodRSS feedShow website
  • 98 episodes
  • Updated Wednesday

Episodes98

Newest first
  • May 1, 2021 · 37 min

    Lanny Sun: Co-founder of Silicon Therapeutics

    Lanny Sun, co-founder of Silicon Therapeutics, recently acquired by Roivant Sciences. speaks with corporate branding veteran John Simboli about leadership in biopharma. Lanny also discusses how Silicon Therapeutics, now part of Roivant Drug Discovery, is advancing its chip-to-clinic, computational quantum physics-based approach to pioneer a new path for drug design of medicines to improve the lives of patients

  • Apr 3, 2021 · 37 min

    Joan Perelló: Co-Founder and CEO of Sanifit

    Joan Perelló, co-founder and CEO of Sanifit, shares his thoughts with BioBoss host John Simboli about leadership and how Sanifit is pursuing the development of treatments for progressive vascular calcification disorders.

  • Mar 13, 2021 · 27 min

    Saiid Zarrabian: CEO of Kintara Therapeutics

    Saiid Zarrabian, President and CEO of Kintara Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and how Kintara is pursuing the development of new cancer therapies for patients with rare unmet medical needs.

  • Feb 7, 2021 · 32 min

    John Temperato: CEO of 9 Meters Biopharma

    John Temperato, President and Chief Executive Officer of 9 Meters Biopharma, speaks with BioBoss host John Simboli about leadership in biopharma and how 9 Meters is advancing drug candidates for patients with rare and unmet gastrointestinal disorders including short bowel syndrome and celiac disease.

  • Jan 10, 2021 · 40 min

    Shawn Singh: CEO of VistaGen Therapeutics

    Shawn Singh, CEO of VistaGen, speaks with BioBoss host John Simboli about leadership and VistaGen's working to develop a new generation of medications for anxiety, depression and other central nervous system disorders.

  • Jan 6, 2021 · 1 min

    Welcome to Season 3 of BioBoss

    BioBoss podcast host John Simboli reflects on the success of seasons 1 and 2 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 3.

  • Dec 8, 2020 · 40 min

    Bobby Gaspar: CEO of Orchard Therapeutics

    Bobby Gaspar, founder and CEO of Orchard Therapeutics, speaks with BioBoss host John Simboli about leadership and how Orchard Therapeutics is pursuing the opportunity to change medicine and change the lives of people with severe genetic diseases.

  • Nov 8, 2020 · 37 min

    Itamar Kandel: CEO of HeartVista

    Itamar Kandel, CEO of HeartVista, speaks with BioBoss host John Simboli about leadership and how HeartVista leverages machine learning to simplify diagnostic imaging and help physicians more accurately diagnose cardiovascular disease.

  • Oct 17, 2020 · 33 min

    Mark Altmeyer: Founder and CEO of Arvelle Therapeutics

    Mark Altmeyer, founder and CEO of Arvelle Therapeutics, speaks with BioBoss host John Simboli. Hear Mark’s thoughts about leadership and how Arvelle is working to bring new solutions to people living with epilepsy and CNS disorders.

  • Sep 26, 2020 · 45 min

    Jacob Becraft: Co-Founder and CEO of Strand Therapeutics

    Jacob Becraft, co-founder & CEO of Strand Therapeutics shares his thoughts with BioBoss host John Simboli about leadership and how Strand is working in synthetic biology and messenger RNA to target root causes of genetic disease, with the power to control editing at a single-cell level.

  • Sep 15, 2020 · 44 min

    Eran Eden: Co-Founder and CEO of MeMed

    Eran Eden, co-founder and CEO of MeMed, shares his thoughts on leadership and how MeMed is working to translate signals from the immune system into diagnostic insights to treat infectious disease and inflammatory disorders.

  • Aug 29, 2020 · 37 min

    Nikolaj Sørensen: CEO of Orexo

    Nikolaj Sørensen, CEO of Orexo Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership and, digital and bio-therapeutics, how the coronavirus is changing the landscape around mental health, depression, substance abuse and addiction,

  • Jul 25, 2020 · 36 min

    Per Hellsund: Co-Founder and CEO of Cybrexa

    Per Hellsund, co-founder and CEO of Cybrexa Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership, building a culture of transparency, and Cybrexa's advances in treating the cancer tumor microenvironment.

  • Jul 11, 2020 · 41 min

    Clive Morris: CEO of Inivata

    CEO Clive Morris of Inivata, headquartered in Cambridge U.K., shares his thoughts with BioBoss host John Simboli about leadership in biotech and advances in non-invasive liquid biopsy to unlock genomic information and guide personalized cancer treatment.

  • Jun 27, 2020 · 33 min

    Samuel Murphy: Co-Founder of Salubris Biotherapeutics

    Salubris Biotherapeutics Co-founder Samuel Murphy shares his thoughts about leadership in biopharma with BioBoss host John Simboli. Samuel also discusses Salubris Biotherapeutics advances in therapeutics for the treatment of cancer, cardiovascular, and metabolic diseases.

  • Jun 13, 2020 · 33 min

    Jason Meyenburg: CEO of Gemini Therapeutics

    Gemini Therapeutics CEO Jason Meyenburg share his thoughts about leadership in biopharma with BioBoss host John Simboli. Jason also discusses Gemini Therapeutics pioneering approach to developing precision medicines by leveraging genetics to work in diseases like dry AMD and linked diseases that have limited or no solutions.

  • Apr 25, 2020 · 44 min

    Ankit Mahadevia: CEO of Spero Therapeutics

    "I really rely on the expertise of the team and I value input. I also value contradiction." - Ankit Mahadevia, founder and CEO of Spero Therapeutics

  • Feb 17, 2020 · 35 min

    Michel Detheux: CEO of iTeos Therapeutics

    "I will always ask myself, what can I do with my knowledge in science to be able to bridge that to patients?" - Michel Detheux, co-founder and CEO of iTeos Therapeutics